Allergan, Inc.Irvine, CA, United States (NYSE: AGN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Allergan Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Quarter
Ending Jun 08
Quarter
Ending Mar 08
Quarter
Ending Dec 07
Quarter
Ending Sep 07
Quarter
Ending Jun 07
Revenue 1,172.0 1,076.6 1,090.6 973.7 988.1
Cost of Goods Sold 197.5 182.2 179.8 159.5 174.5
Gross Profit 974.5 894.4 910.8 814.2 813.6
Gross Profit Margin 83.1% 83.1% 83.5% 83.6% 82.3%
SG&A Expense 699.9 663.9 632.2 536.2 578.3
Depreciation & Amortization 65.6 64.5 60.2 54.1 53.6
Operating Income 209.0 166.0 218.4 223.9 181.7
Operating Margin 17.8% 15.4% 20.0% 23.0% 18.4%
Nonoperating Income 1.9 5.0 8.3 8.3 10.1
Nonoperating Expenses 14.8 15.4 17.9 17.5 17.5
Income Before Taxes 196.1 155.6 208.8 214.7 174.3
Income Taxes 48.4 44.0 47.5 56.5 36.0
Net Income After Taxes 147.7 111.6 161.3 158.2 138.3

Continuing Operations 147.3 111.4 161.2 158.2 137.8
Discontinued Operations -- -- (0.9) (0.8) --
Total Operations 147.3 111.4 160.3 157.4 137.8
Total Net Income 147.3 111.4 160.3 157.4 137.8
Net Profit Margin 12.6% 10.3% 14.7% 16.2% 13.9%

Diluted EPS from Total Net Income ($) 0.48 0.36 0.52 0.51 0.45
Dividends per Share 0.05 0.05 0.05 0.05 0.05
Edgar Online logo
This data is provided as per license from EDGAR Online